Search

Subject Coronary microvascular dysfunction -- Angina

1. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. (27th November 2015)

Authors:
Bairey Merz, C. Noel; Handberg, Eileen M.; Shufelt, Chrisandra L.; Mehta, Puja K.; Minissian, Margo B.; Wei, Janet; Thomson, Louise E.J.; Berman, Daniel S.; Shaw, Leslee J.; Petersen, John W.; Brown, Garrett H.; Anderson, R. David; Shuster, Jonathan J.; Cook-Wiens, Galen; Rogatko, André; Pepine, ...
Journal:
European heart journal
Issue:
Volume 37:Number 19(2016:May)
Page Start:
1504
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • Coronary microvascular dysfunction -- Angina 1